Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer
Current Issues in Molecular Biology · 13.02.2025 · 47 (2) · 121
DOI: 10.3390/cimb47020121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 13.02.2025. Verfasst von Seda Er Özilhan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Ankara Bilkent City Hospital, Ankara 06800, Turkey. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lung cancer remains the leading cause of cancer-related deaths worldwide, with non-small cell lung carcinomas (NSCLCs) comprising the majority of cases. Among the common driver mutations, KRAS plays a critical role in guiding treatment strategies. This study evaluates the expression of programmed death-ligand 1 (PD-L1) and hypoxia-inducible factor 1-alpha (HIF-1α) in KRAS-mutant NSCLCs and investigates their associations with clinicopathological findings.
Methods
A total of 85 cases with KRAS mutations were analyzed. Immunohistochemical staining for HIF-1α and PD-L1 was performed, and their relationships with mutation status and prognostic variables were assessed.
Results
A significant correlation was identified between HIF-1α expression and PD-L1 expression in tumor cells. While the KRAS G12C mutation was not significantly associated with HIF-1α expression in tumor cells, it demonstrated a notable relationship with HIF-1α expression in the tumor microenvironment and PD-L1 expression. However, PD-L1 and HIF-1α expression did not significantly influence overall survival outcomes.
Conclusions
Expression of PD-L1 was positively correlated with HIF-1α, which may provide evidence for a novel therapy targeting PD-L1 and HIF-1α in NSCLC. Further comprehensive studies are warranted to elucidate the prognostic implications of tumor–microenvironment and mutation interactions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Ankara Bilkent City Hospital, Ankara 06800, Turkey.
- Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara 06800, Turkey.
- Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06800, Turkey.
- Department of Pathology, Ankara Atatürk Sanatoryum Hospital, Health Sciences University, Ankara 06290, Turkey.
- Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06800, Turkey.
- Department of Pathology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06800, Turkey.
ORCID-Profile: Seda Er Özilhan, Safa Can Efil, Doğukan Çanakçı, Yetkin Ağaçkıran, Didem Şener Dede, Mehmet Doğan, Tuba Dilay Kökenek Ünal, Merve Meryem Kıran, Serra Kayaçetin, Hilal Balta, Hayriye Tatlı Doğan
Zitieren
APA
Er Özilhan, S., Efil, S. C., Çanakçı, D., Ağaçkıran, Y., Şener Dede, D., Onak Kandemir, N., Doğan, M., Ünal, T. D. K., Kıran, M. M., Kayaçetin, S., Balta, H., & Tatlı Doğan, H. (2025). Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer. Current Issues in Molecular Biology, 47(2), 121. https://doi.org/10.3390/cimb47020121
Vancouver
Er Özilhan S, Efil SC, Çanakçı D, Ağaçkıran Y, Şener Dede D, Onak Kandemir N, et al. Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer. Current Issues in Molecular Biology. 2025;47(2):121. doi:10.3390/cimb47020121
BibTeX
@article{Erzilhan2025,
author = {Er Özilhan, Seda and Efil, Safa Can and Çanakçı, Doğukan and Ağaçkıran, Yetkin and Şener Dede, Didem and Onak Kandemir, Nilüfer and Doğan, Mehmet and Ünal, Tuba Dilay Kökenek and Kıran, Merve Meryem and Kayaçetin, Serra and Balta, Hilal and Tatlı Doğan, Hayriye},
title = {Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {2},
pages = {121},
doi = {10.3390/cimb47020121}
}
EUVIMED